Document is current
Any future updates will be listed below
-
Authors
Popat, Rakesh https://orcid.org/0000-0001-6553-4618
Augustson, Bradley
Gironella, Mercedes https://orcid.org/0000-0002-8106-8909
Lee, Cindy
Cannell, Paul
Patel, Nashita
Kasinathan, Ravi S.
Rogers, Rachel
Shaikh, Mehreen
Curry, Amy
Carreño, Fernando
Roy-Ghanta, Sumita
Opalinska, Joanna
Quach, Hang https://orcid.org/0000-0002-4796-3352
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 12 June 2024
Revised: 18 September 2024
Accepted: 24 September 2024
First Online: 21 October 2024
Competing interests
: RP is supported by the Biomedical Research Center of the National Institute for Health Research and University College London Hospitals and received speaker honorarium from AbbVie, GSK, Janssen Biotech, Inc., BMS and Pfizer, has participated in advisory boards for GSK and Janssen Biotech, Inc., and has received research funding from GSK and Pfizer. BA has sat on scientific advisory boards for Janssen-Cilag Pty Ltd. MG discloses no conflicts of interest. CL has participated in advisory boards for Janssen-Cilag, BMS, Antengene, Takeda, and Amgen. PC discloses no conflicts of interest. NP, RSK, RR, MS, AC, FC, SR-G, and JO are employees of GSK and hold stocks/shares in GSK. HQ has received research funding from GSK, BMS, Karyopharm, and Abbvie, has received speaker honorarium for Beigene, GSK, and Abbvie and has participated on advisory boards for BMS, Abbvie, GSK, Janssen Cilag, Pfizer, Antengene, Sanofi and Regeneron.
